Rituximab Regimen Improves Survival in Children With Aggressive B-Cell Lymphoma
- OPACC
- Jul 6, 2020
- 1 min read
Adding rituximab (Rituxan, Truxima) to chemotherapy may be a new standard for treating children and young adults newly diagnosed with aggressive B-cell lymphoma, according to findings from a randomized, international, phase 3 trial.
Comments